Physician profile
Mitchell Alden
NPI 1861474991
$19,711.11
in general payments reported to CMS, 2019-2025
95 companies · $3,685 in 2025
The $3,685 reported for 2025 was more than what 78% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,422 · 2020: $1,875 · 2021: $2,429 · 2022: $2,434 · 2023: $3,067 · 2024: $3,798 · 2025: $3,685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,304 · Long Term Medical Supply Or Device Loan: $997 · Education: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,303.92 |
| Long Term Medical Supply Or Device Loan | $997.00 |
| Education | $249.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,944.14 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,365.87 | 2019-2025 | Calquence, Enhertu, Tagrisso |
| Janssen Biotech, INC. | $1,068.21 | 2019-2025 | Darzalex, Tecvayli, Carvykti |
| E.R. Squibb & Sons, L.L.C. | $925.44 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Merck Sharp & Dohme LLC | $911.23 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Daiichi Sankyo INC. | $702.92 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Glaxosmithkline, LLC. | $686.66 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Genzyme Corporation | $680.05 | 2019-2025 | |
| Pfizer INC. | $669.24 | 2019-2025 | |
| Celgene Corporation | $579.70 | 2019-2025 | Reblozyl, Pomalyst |
| Eisai INC. | $547.59 | 2019-2025 | |
| Incyte Corporation | $535.01 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Lilly USA, LLC | $511.66 | 2019-2024 | Verzenio, Jaypirca, Retevmo |
| Abbvie INC. | $497.78 | 2019-2025 | Venclexta |
| Amgen INC. | $488.58 | 2019-2023 | Nplate, Xgeva, Vectibix |
Show all 95 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $486.80 | 2019-2025 | Xtandi, Padcev, Vyloy |
| Genentech USA, INC. | $452.30 | 2019-2025 | Phesgo, Perjeta, Kadcyla |
| Seagen INC. | $408.03 | 2019-2025 | Adcetris, Tukysa |
| Gilead Sciences, INC. | $314.75 | 2019-2025 | Trodelvy |
| Genmab U.S., INC. | $307.25 | 2021-2025 | Tivdak, Epkinly |
| Takeda Pharmaceuticals U.S.A., INC. | $252.21 | 2019-2025 | Ninlaro, Fruzaqla |
| Pharmacyclics LLC, An Abbvie Company | $240.88 | 2019-2023 | Imbruvica, Epkinly |
| Stemline Therapeutics INC. | $229.17 | 2020-2025 | Orserdu |
| Alexion Pharmaceuticals, INC. | $219.49 | 2019-2025 | Ultomiris |
| Beigene USA, INC. | $213.35 | 2020-2024 | Brukinsa |
| Dendreon Pharmaceuticals LLC | $207.04 | 2019-2023 | Provenge |
| Regeneron Healthcare Solutions, INC. | $177.68 | 2021-2025 | Libtayo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $174.31 | 2020-2025 | |
| Aveo Pharmaceuticals, INC. | $161.16 | 2021-2024 | Fotivda |
| Sobi, INC | $157.25 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $150.58 | 2019-2025 | Onivyde, Somatuline Depot |
| Bayer Healthcare Pharmaceuticals INC. | $138.45 | 2019-2025 | |
| Tersera Therapeutics LLC | $135.99 | 2021-2023 | Zoladex |
| Servier Pharmaceuticals LLC | $132.48 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $104.76 | 2021-2023 | Myrisk |
| Pharmacosmos Therapeutics INC. | $103.35 | 2020-2024 | Monoferric |
| Taiho Oncology, INC. | $101.17 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $101.01 | 2019-2024 | |
| Array Biopharma INC | $96.78 | 2020-2025 | Mektovi, Braftovi, Lorbrena |
| Kite Pharma, INC. | $95.52 | 2020-2025 | Yescarta |
| Karyopharm Therapeutics INC. | $94.31 | 2020-2025 | Xpovio |
| Blueprint Medicines Corporation | $94.02 | 2020-2024 | Ayvakit |
| Rigel Pharmaceuticals, INC. | $90.23 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Novocure INC. | $88.82 | 2024-2025 | Optune Lua (Novottf-200t), Optune |
| Puma Biotechnology, INC. | $84.30 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $82.32 | 2022-2023 | Givlaari |
| Tesaro, INC. | $80.94 | 2019 | |
| Beone Medicines USA, INC. | $80.81 | 2025 | Brukinsa, Tevimbra |
| Mirati Therapeutics, INC. | $78.39 | 2023-2024 | Krazati |
| Kyowa Kirin, INC. | $75.12 | 2021-2023 | Poteligeo |
| Tempus Ai, INC | $69.86 | 2024 | |
| Recordati_rare_diseases_inc. | $68.54 | 2025 | Sylvant, Panhematin |
| Lexicon Pharmaceuticals, INC. | $64.85 | 2019-2020 | |
| Morphosys, US INC. | $61.36 | 2022-2023 | Monjuvi |
| Adaptive Biotechnologies Corporation | $60.36 | 2022-2023 | Clonoseq |
| Ge Healthcare | $58.84 | 2021-2022 | |
| Blue Earth Diagnostics | $57.43 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $56.95 | 2023-2025 | Orgovyx |
| Myovant Sciences INC. | $55.87 | 2021-2022 | |
| Emd Serono, INC. | $53.43 | 2019-2021 | |
| Dova Pharmaceuticals | $52.91 | 2021 | |
| Exelixis INC. | $50.71 | 2019-2025 | Cabometyx |
| Epizyme, INC. | $49.85 | 2021 | |
| Progenics Pharmaceuticals, INC. | $49.05 | 2022-2025 | |
| Clovis Oncology, INC. | $47.90 | 2019-2022 | |
| G1 Therapeutics, INC. | $45.49 | 2022 | |
| Welch Allyn | $44.36 | 2021 | |
| Telix Pharmaceuticals | $39.92 | 2023-2024 | Illuccix |
| Integra Lifesciences Corporation | $38.41 | 2024 | Codman Hakim, Cusa Clarity, Codman Certas |
| Verastem, INC. | $38.00 | 2019 | |
| Sun Pharmaceutical Industries INC. | $37.77 | 2021 | |
| Apellis Pharmaceuticals, INC. | $35.05 | 2024 | Empaveli |
| Foundation Medicine, INC. | $33.67 | 2019-2021 | |
| Immunogen, INC. | $29.73 | 2023 | Elahere |
| Geron Corporation | $27.43 | 2025 | Rytelo |
| Legend Biotech USA INC. | $26.69 | 2025 | Carvykti |
| Syndax Pharmaceuticals, INC. | $26.06 | 2025 | Revuforj |
| Caris Mpi, INC. | $23.59 | 2025 | Mi Cancer Seek |
| Aurobindo Pharma USA, INC. | $21.47 | 2020 | |
| Secura Bio, INC. | $21.44 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $21.38 | 2019 | |
| Verity Pharmaceuticals INC. | $21.22 | 2022 | |
| Adc Therapeutics America, INC. | $19.74 | 2025 | |
| Deciphera Pharmaceuticals INC. | $16.83 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $16.74 | 2022 | |
| Acrotech Biopharma INC. | $16.15 | 2025 | Beleodaq |
| Mylan Institutional INC. | $15.31 | 2020 | |
| Medtronic, INC. | $14.98 | 2021 | |
| Eusa Pharma (US) LLC | $14.88 | 2019 | |
| Fennec Pharmaceuticals, INC. | $14.83 | 2024 | Pedmark |
| Teva Pharmaceuticals USA, INC. | $14.23 | 2019 | |
| Bio Products Laboratory USA, INC. | $13.78 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.47 | 2019 | |
| Innate Pharma, INC | $13.22 | 2020 | |
| Fortovia Therapeutics, INC. | $12.26 | 2019 |
Drugs and devices associated with these payments
Kisqali $1,212Keytruda $486Enhertu $395Imbruvica $343Lenvima $326Zejula $310Jemperli $310Reblozyl $282Calquence $271Darzalex $242Tecvayli $227Epkinly $212Lynparza $200Carvykti $197Orserdu $196Monjuvi $176Opdivo $171Xtandi $166Jakafi $160Sarclisa $158Ojjaara $152Elahere $144Tagrisso $140Talvey $139Scemblix $133Venclexta $125Tivdak $122Ayvakit $120Ultomiris $120Brukinsa $116Tukysa $114Piqray $109Libtayo $109Pemazyre $108Injectafer $107Krazati $103Opdualag $101Wayrilz $101Erleada $95.92Ibrance $95.28Vonjo $92.24Fabhalta $90.89Orgovyx $87.01Ninlaro $86.64Paxlovid $83.25Illuccix $79.84Fotivda $79.58Inlyta $78.21Mekinist $74.87Verzenio $73.79Padcev $70.11Rybrevant $69.46Phesgo $67.31Pluvicto $65.82Monoferric $63.10Nubeqa $62.56Poteligeo $58.54Nplate $53.75Givlaari $50.61Cablivi $48.43Optune Lua (Novottf-200t) $47.81Trodelvy $47.67Eliquis $47.33Rezlidhia $46.95Tavalisse $46.95Onivyde $46.60Somatuline Depot $46.60Sylvant $46.55Keytruda Qlex $46.01Fruzaqla $45.45Lonsurf $45.36Inqovi $45.36Doptelet $45.22Provenge $44.07Imfinzi $44.06Zoladex $43.96Clonoseq $43.96Adcetris $43.86Stivarga $43.66Kadcyla $43.54Perjeta $43.54Yescarta $41.42Optune $41.01Elitek $38.93Talzenna $38.43Codman Certas $38.41Codman Hakim $38.41Duraseal Exact Spinal Sealant System $38.41Cusa Clarity $38.41Zepzelca $36.91Tibsovo $36.58Comirnaty $35.92Empaveli $35.05Xpovio $34.79Polivy $32.88Columvi $32.21Myrisk $29.52Pylarify $29.21Promacta $28.70Rytelo $27.43
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Alden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.